immunotherapy based biotechs into 2012, page-8

So all is positive....

I tend to agree, I can't find any downsides to this stock.
It may take a hit if DNDN's figures, due out on 28th are no good. I know it shouldn't matter but the fact is it does, PRR will react to these figures.

SO does anyone have any idea or estimate as to when the listing will be announced, from what I can make of it it will be in the next 6 to 8 weeks as PRR did not file a form 3F (from memory)

Also I am a bit too inexperienced to fully understand why and how stocks are sold down, I understand it is the big boys dumping stocks to push the price down so they can acquire more at a lower price, is this correct?
If so will this still be happening when the listing is announced and the US bank starts buying or do you feel this will trigger a push upwards that can't be contained by the down sellers.

Anyones thoughts appreciated